Vitamin A supplements : a guide to their use in the treatment and prevention of vitamin A deficiency and xerophthalmia
| 000 | 00000cam u2200205 a 4500 | |
| 001 | 000000590726 | |
| 005 | 20240819174626 | |
| 008 | 921117s1988 sz b i000 0 eng d | |
| 010 | ▼a 89140713 //r94 | |
| 020 | ▼a 9241542365 : ▼c Sw.fr. 8.00 | |
| 040 | ▼a DNLM ▼c DLC ▼d NLM ▼d PPC ▼d MDU ▼d WAU ▼d 211009 | |
| 042 | ▼a lccopycat | |
| 049 | 1 | ▼l 481031868 ▼f UN-W |
| 050 | 0 4 | ▼a RC627.V54 ▼b W46 1988 |
| 060 | 0 | ▼a WD 110 ▼b V8374 1988 |
| 082 | 0 4 | ▼a 615.328 ▼2 21 |
| 090 | ▼a 615.328 ▼b vs | |
| 110 | 2 | ▼a WHO ▼0 AUTH(211009)64026. |
| 245 | 1 0 | ▼a Vitamin A supplements : ▼b a guide to their use in the treatment and prevention of vitamin A deficiency and xerophthalmia / ▼c prepared by a WHO/UNICEF/IVACG Task Force. |
| 260 | ▼a Geneva : ▼b World Health Organization ; ▼a Albany, NY : ▼b WHO Publication Center, ▼c 1988. | |
| 300 | ▼a 24 p. ; ▼c 25 cm. | |
| 504 | ▼a Includes bibliographical references (p. 19-20). | |
| 650 | 0 | ▼a Vitamin A deficiency. |
| 650 | 0 | ▼a Vitamin A. |
| 650 | 0 | ▼a Xerophthalmia. |
| 650 | 2 | ▼a Vitamin A ▼x therapeutic use. |
| 650 | 2 | ▼a Vitamin A Deficiency ▼x drug therapy. |
| 650 | 2 | ▼a Vitamin A Deficiency ▼x prevention & control. |
| 650 | 2 | ▼a Xerophthalmia ▼x drug therapy. |
| 650 | 2 | ▼a Xerophthalmia ▼x prevention & control. |
| 710 | 2 | ▼a World Health Organization. |
| 710 | 2 | ▼a WHO/UNICEF/IVACG Task Force. |
| 710 | 2 | ▼a UNICEF ▼0 AUTH(211009)164536. |
| 710 | 2 | ▼a United Nations Children's Fund. |
| 710 | 2 | ▼a International Vitamin A Consultative Group. |
소장정보
| No. | 소장처 | 청구기호 | 등록번호 | 도서상태 | 반납예정일 | 예약 | 서비스 |
|---|---|---|---|---|---|---|---|
| No. 1 | 소장처 학술정보관(CDL)/B1 국제기구자료실(UN)/UN-W | 청구기호 615.328 vs | 등록번호 481031868 | 도서상태 대출불가(자료실) | 반납예정일 | 예약 | 서비스 |
컨텐츠정보
목차
목차 Perface = 5 1. Introduction = 7 2. Treatment of xerophthalmia = 8 Children under 6years old = 8 Children aged 6years or over, adolescents, and adults = 9 Women of reproductive age, pregnant or not = 9 3. Prevention of vitamin A deficiency, xerophthalmia, and nutritional blindness in children = 10 Rationale = 10 Safety = 10 Disease-targeted distribution = 10 Universal distribution = 11 4. Operational matters = 13 Vitamin A preparations = 13 Logistics = 14 Training = 17 Monitoring and evaluation = 18 Selected bibliography = 19 Annex 1. Participants in the WHO/UNICEF/IVACG Task Force = 21 Annex 2. Countries categorized by degree of public health significance of vitamin A deficiency, xerophthalmia, and nutritional blindness = 22 Annex 3. Data on the stability of commonly supplied vitamin A preparations = 24
